Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Twelve hallmarks of aging: evidence reviewed, human translation unresolved

This abstract reviews mechanistic and translational evidence for all twelve hallmarks of aging, expanded from nine in 2023. Model-organism studies support causal roles for several hallmarks, but their priority, necessity, sufficiency, tissue specificity and relevance to human aging remain unresolved. [1]

Automatic summary · not editorially reviewed

The key findings

  1. In 2023 the hallmarks framework was expanded from nine to twelve by adding disabled macroautophagy, chronic inflammation and dysbiosis. [1]

  2. RNA-processing defects and extracellular matrix remodeling are examined as candidate processes but not classified as an additional hallmark. [1]

  3. Model-organism studies support causal roles for several hallmarks, yet causal priority, necessity, sufficiency, tissue specificity and relevance to human aging remain unresolved. [1]

The source at a glance

Study type / format
Review abstract evaluating mechanistic and translational evidence
Population / context
Molecular and cellular aging processes described in the hallmarks framework; no human participants reported in the abstract.
Summary based on
Study abstract
Original publication
September 11, 2026

Framework expanded from nine to twelve hallmarks

The abstract describes aging as a gradual decline in structure and function, with loss of physiological integrity, adaptive capacity and resilience and rising vulnerability to disease, disability and death. The hallmarks framework is presented as a widely used, experimentally tractable taxonomy of molecular and cellular processes associated with aging. In 2023, López-Otín and colleagues expanded it from nine to twelve hallmarks by adding disabled macroautophagy, chronic inflammation and dysbiosis.

Supporting source [1]

Model-organism causality versus unresolved human relevance

The authors evaluate mechanistic and translational evidence for all twelve hallmarks. They also examine RNA-processing defects and extracellular matrix remodeling as candidate processes, without classifying either as an additional hallmark. Experimental studies in model organisms support causal roles for several hallmarks. However, the abstract states that their causal priority, necessity, sufficiency, tissue specificity and relevance to human aging remain unresolved.

Supporting source [1]

Translation barriers and proposed study approach

Clinical translation is described as limited by pleiotropy (one factor affecting several traits), compensatory responses, heterogeneous trajectories, uncertain biomarkers and the long period needed to detect meaningful outcomes. The authors propose that future geroscience studies treat hallmarks as provisional causal modules within interacting physiological networks, select mechanism-linked and function-centered endpoints, and test interventions against prospectively defined claims.

Supporting source [1]

How to interpret this

This is an abstract only; the full text was not reviewed. Design, sample and follow-up are not reported in the abstract, and the unresolved points above are stated by the authors themselves.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
The Hallmarks of Aging: From Molecular Mechanisms to Clinical Translation.

Chmielewski PP, Strzelec B. · europepmc.org · September 11, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    expanded the framework from nine to twelve
  2. Finding 2 ↑

    without classifying either as an additional hallmark
  3. Finding 3 ↑

    relevance to human aging remain unresolved

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…